Arkadi Yakirevitch

Arkadi Yakirevitch

Auto-generated profile, based on publicly available information

Arkadi Yakirevitch

Tel Aviv University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
GKGilmor I. Keshet
Gilmor I. Keshet
IGItamar Goldstein
Itamar Goldstein
OIOrit Itzhaki
Orit Itzhaki
KCKaren Cesarkas
Karen Cesarkas
LSLiraz Shenhav
Liraz Shenhav
GRGideon Rechavi
Gideon Rechavi

1 March 2010 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
PNPiero Nicolai
Piero Nicolai
AVAndrea Bolzoni Villaret
Andrea Bolzoni Villaret
DFDavide Farina
Davide Farina
SNSylvie Nadeau
Sylvie Nadeau
AYArkadi Yakirevitch
Arkadi Yakirevitch
CGCristina Galtelli
Cristina Galtelli
Background: At present, transnasal endoscopic surgery is considered a viable option in the management of small–intermediate size juvenile angiofibromas (JAs). The authors critically review their 14-year experience in the management of this lesion to refine selection criteria for an endoscopic approach. Methods: From January 1994 to May 2008, 46 patients were treated by a pure endoscopic resection after vascular embolization (87%). The lesions were classified according to Andrews (Andrews JC, et al., The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach, Laryngoscope 99:429–437, 1989) and Önerci (Önerci M, et al. Juvenile nasopharyngeal angiofibroma: A revised staging system, Rhinology 44:39–45, 2006) staging systems. All patients were followed by regular endoscopic and magnetic resonance imaging (MRI) examinations. Results: Lesions were classified as follows: stage I, n = 5; stage II, n = 24; stage IIIa, n = 14; stage IIIb, n = 3 according to Andrews classification system; stage 1, n = 9; stage II, n = 12; stage III, n = 26 according to Önerci's system. Unilateral blood supply was detected in 39 (85%) cases. Feeding vessels from the internal carotid artery (ICA) were also reported in 14 (30%) patients. Intraoperative blood loss ranged from 250 to 1300 mL (mean, 580 mL). In four (8.7%) cases, suspicious residual disease was detected by MRI. In one patient, a 1-cm persistent lesion was endoscopically removed because septoplasty was required and a slight increase in size was noticed. The other three lesions, all located in the root of the pterygoid plate, are nearly stable in size and are currently under MRI follow-up. Conclusion: The improvement of surgical instrumentation and the experience acquired during a 14-year period have contributed to expanding the indications for endoscopic surgery in the management of JAs. Even stage III lesions may be successfully managed, unless the ICA is encased or if it provides an extensive blood supply. An external approach may be required when critical structures such as the ICA, cavernous sinus, or optic nerve are involved by lesions that are persistent after previous treatment; such a situation may prevent safe and radical dissection with a pure endoscopic approach. Better understanding of the factors influencing the growth of residual lesions is needed to differentiate those requiring re-treatment from those which can be simply observed.

1 January 2010 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
AVAndrea Bolzoni Villaret
Andrea Bolzoni Villaret
AYArkadi Yakirevitch
Arkadi Yakirevitch
ABAndrea Bizzoni
Andrea Bizzoni
RBRoberta Bosio
Roberta Bosio
MBMaurizio Bignami
Maurizio Bignami
PNPiero Nicolai
Piero Nicolai
Background: Because of a better understanding of the anatomy from an endoscopic perspective, the acquisition of surgical experience, and concomitant technological advances, endoscopic resection of the anterior skull base (ASB) and overlying dura has now become a reality, opening new possibilities in the management of sinonasal malignancies. Here, the authors review a series of 62 patients, the largest reported to date, who underwent endoscopic transnasal craniectomy (ETC) and endoscopic dural repair for the management of selected sinonasal malignancies. Special emphasis is placed on the surgical technique, technical tricks, choice of materials for endoscopic dural repair, postoperative management, and complications. Methods: From 2004, 62 patients underwent ETC at two referral hospitals, which extended anteroposteriorly from the frontal sinus to planum sphenoidale and laterolaterally from the nasal septum to the lamina papyracea (unilateral resection, n = 28; 45%) or from papyracea to papyracea (bilateral resection, n = 34; 55%). Duraplasty with a three-layer technique was performed using the iliotibial tract and fat tissue. Results: The most frequent histotypes were adenocarcinoma (58%) and olfactory neuroblastoma (22%). Forty-five (73%) patients were previously untreated. The incidence of early (T1–2, Kadish A-B) and advanced (T3–4, Kadish C) tumors was similar. The complication rate was 15%, mostly cerebrospinal fluid leaks (13%). Its prevalence did not correlate with patient age, medical comorbidities, previous treatment, presence of ASB involvement, or whether ETC was mono- or bilateral, but tended to correlate with advanced tumor stage, dural involvement, and the period of treatment. After a mean follow-up of 17.5 months (range, 1–54 months), 58 (94%) patients had no evidence of disease. Conclusions: In correctly selected patients with sinonasal tumors involving the ASB, ETC offers a less invasive alternative than resection by an open approach with an acceptable morbidity.

1 May 2006 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
LMLela Migirov
Lela Migirov
AYArkadi Yakirevitch
Arkadi Yakirevitch
YHYael Henkin
Yael Henkin
RKRicky Kaplan-Neeman
Ricky Kaplan-Neeman
JKJona Kronenberg
Jona Kronenberg

1 June 2006 in ORL
Verified
Journal Article
Closed access
LMLela Migirov
Lela Migirov
AYArkadi Yakirevitch
Arkadi Yakirevitch
JKJona Kronenberg
Jona Kronenberg
Our study was designed to evaluate the complication rate of cochlear implantation (CI) and to compare two different surgical approaches that are currently being used for implantations in our department. This retrospective study was conducted on the patients who underwent CI in our center between 1989 and 2003 and who were followed-up for at least 18 months. The patients were divided into two groups according to the surgical technique that had been used for the implantation: the mastoidectomy with posterior tympanotomy approach and the suprameatal approach (without mastoidectomy). The incidence of complications following CI was compared between the two groups and between children and adults. Facial nerve paralysis, electrode misplacement, injury to the chorda tympani nerve and mastoiditis occurred only in the mastoidectomy with posterior tympanotomy approach group. Acute middle ear infection with or without mastoiditis emerged as the most common complication in both groups, followed by vestibular and wound problems. Disequilibrium was significantly more common among the adults than among the children (p < 0.0001). The suprameatal approach was demonstrated as being a good alternative technique to the classical surgery for CI.

4 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MBMichal J. Besser
Michal J. Besser
TSTsipi Shoham
Tsipi Shoham
OHOrit Harari-Steinberg
Orit Harari-Steinberg
NZNaama Zabari
Naama Zabari
RORona Ortenberg
Rona Ortenberg
GMGal Markel
Gal Markel
Natural killer (NK) cells have long been considered as potential agents for adoptive cell therapy for solid cancer patients. Until today most studies utilized autologous NK cells and yielded disappointing results. Here we analyze various modular strategies to employ allogeneic NK cells for adoptive cell transfer, including donor-recipient HLA-C mismatching, selective activation and induction of melanoma-recognizing lysis receptors, and co-administration of antibodies to elicit antibody-dependent cell cytotoxicity (ADCC). We show that NK cell activation and induction of the relevant lysis receptors, as well as co-administration of antibodies yield substantial anti-cancer effects, which are functionally superior to HLA-C mismatching. Combination of the various strategies yielded improved effects. In addition, we developed various clinically-compatible ex vivo expansion protocols that were optimized according to fold expansion, purity and expression of lysis receptors. The main advantages of employing allogeneic NK cells are accessibility, the ability to use a single donor for many patients, combination with various strategies associated with the mechanism of action, e.g. antibodies and specific activation, as well as donor selection according to HLA or CD16 genotypes. This study rationalizes a clinical trial that combines adoptive transfer of highly potent allogeneic NK cells and antibody therapy.